Sign In
Buy JNJ
$244.88
+3.88 (+1.61%)
At Close: Jun 25, 2026
2 Average Stocks That Could Make You Rich
09:10am, Saturday, 13'th Jan 2024
Companies that sell everyday products you know well may be the key to your future wealth. They may offer you earnings growth over time and annual dividend payments.
Johnson & Johnson (JNJ) is Attracting Investor Attention: Here is What You Should Know
10:32am, Friday, 12'th Jan 2024
Recently, Zacks.com users have been paying close attention to Johnson & Johnson (JNJ). This makes it worthwhile to examine what the stock has in store.
Dividend Dynasty: 7 High-Yield Stocks for Long-Term Wealth Accumulation
03:05pm, Thursday, 11'th Jan 2024
For inventors looking for a financial compass to navigate the sea of investments, here is the realm of the “Dividend Dynasty.” Here, seven high-yield stocks stand as pillars of long-term wealth ac
These Dividend Kings Have Raised Their Payouts for 60 Years or More.
08:38am, Thursday, 11'th Jan 2024
Investing in companies that have raised their payouts annually for six decades or more has paid off over the long haul.
3 Dividend Aristocrats Signal Buy In January With 7 To Watch
02:05pm, Wednesday, 10'th Jan 2024
"Dividend Aristocrats. in the S&P 500 Index… have raised their annual payouts every year for at least 25 consecutive years."--Kiplinger.com/Investing.
Will Q4 Earnings Push Dow ETF Higher?
12:47pm, Wednesday, 10'th Jan 2024
Let's delve deeper into the probable fourth-quarter earnings picture that will likely aid Dow ETF in the coming days.
Is Johnson & Johnson Stock a Buy Now?
05:25am, Wednesday, 10'th Jan 2024
Johnson & Johnson expects to grow its business by mid-single digits until the end of the decade. The company has been investing billions in expanding its growth opportunities.
Johnson & Johnson (JNJ) Ascends While Market Falls: Some Facts to Note
06:47pm, Tuesday, 09'th Jan 2024
The latest trading day saw Johnson & Johnson (JNJ) settling at $161.63, representing a +0.06% change from its previous close.
Biotech ETFs Stage Solid Comeback at the Start of 2024
12:47pm, Tuesday, 09'th Jan 2024
The biotech space staged a strong comeback at the start of 2024, driven by multi-billion dollar deals, upbeat clinical results and cutting-edge medical advances like CRISPR gene-editing hitting prime-
Sell Alert: The Slaughter Of Office REITs Is Just Beginning
11:20am, Tuesday, 09'th Jan 2024
Office REITs are facing challenges as the hybrid work model becomes more popular, leading to downsizing and increased vacancies. Major companies like Charles Schwab, Johnson & Johnson, Dropbox, and Mi
Johnson & Johnson (JNJ) J.P. Morgan 42nd Annual Healthcare Conference (Transcript)
04:31pm, Monday, 08'th Jan 2024
Johnson & Johnson (JNJ) J.P. Morgan 42nd Annual Healthcare Conference (Transcript)
Johnson & Johnson Pays $2 Billion for Ambrx to Boost Its Cancer Drug Pipeline
03:00pm, Monday, 08'th Jan 2024
Ambrx Biopharma Inc. (AMAM) shares more than doubled Monday on news that Johnson & Johnson (J&J) (JNJ) would purchase the biotechnology firm to add to its cancer-fighting drug portfolio.
Johnson & Johnson Will Pay $700 Million To Resolve Baby Powder Marketing Probe, Report Says
11:02am, Monday, 08'th Jan 2024
Johnson & Johnson will pay an estimated $700 million to resolve an investigation by more than 40 states into the pharmaceutical firm's marketing of its talcum powder, according to Bloomberg, following
J&J to pay $700 million to settle states' talc-marketing probe - Bloomberg News
10:01am, Monday, 08'th Jan 2024
Johnson & Johnson has tentatively agreed to pay about $700 million to resolve an investigation by over 40 U.S. states into claims it wrongfully marketed its talc-based baby powder, Bloomberg News repo
J&J, Merck, Boston Scientific Debut Trio Of Splashy Takeovers Topping $3 Billion In Value
09:19am, Monday, 08'th Jan 2024
J&J, Merck and Boston Scientific kicked off the year's biggest medical conference with a trio of takeovers. AMAM stock and HARP stock soared.
